Back to top

NOTE PURCHASE AGREEMENT

Note Purchase Agreement

NOTE PURCHASE AGREEMENT | Document Parties: BIOLIFE SOLUTIONS INC | BioLife Solutions, Inc You are currently viewing:
This Note Purchase Agreement involves

BIOLIFE SOLUTIONS INC | BioLife Solutions, Inc

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: NOTE PURCHASE AGREEMENT
Governing Law: Delaware     Date: 4/1/2008
Industry: Medical Equipment and Supplies     Sector: Healthcare

NOTE PURCHASE AGREEMENT, Parties: biolife solutions inc , biolife solutions  inc
50 of the Top 250 law firms use our Products every day

Exhibit 10.19


NOTE PURCHASE AGREEMENT


This Note Purchase Agreement (this "Agreement") is entered into this 4th day of September, 2007, by and between BioLife Solutions, Inc., a Delaware corporation having its executive offices at 3303 Monte Villa Parkway, Suite 310, Bothell, WA 98021 (the "Company") and Walter Villiger, with an address at Paradiesstrasse 35, CH-8645, Jona, Switzerland (the "Investor").


W I T N E S S E T H :


WHEREAS, the Company is seeking to raise up to $1,000,000 through the sale of  promissory notes bearing interest at the rate of seven percent (7%) per annum (each, a “Note”), which Note, plus all accrued interest thereon, (a) shall become due and payable in one lump sum on the earlier of (i) September 30, 2008  or (ii) an Event of Default (as defined in the Note), and (b), at the option of the Investor, may be converted into New Equity Securities (as defined in the Note) upon the consummation of a Financing (as defined in the Note) at a per share or per unit price equal to 100% of the per share or per unit purchase price of the New Equity Securities sold in the Financing; and


WHEREAS, the Company anticipates contracting for the sale of the Notes with non U.S. Persons (the term "U.S. Persons" being defined in Regulation S ("Regulation S") of the Securities Act of 1933, as amended (the "Act")), in reliance upon an exemption from registration provided for under Regulation S of the Act; and


WHEREAS, the Company desires to sell to the Investor, and the Investor desires to purchase from the Company, a Note in the principal amount of $500,000;


NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein, the parties agree as follows:


1.

Purchase and Sale of Note; Delivery of Securities; Payment; Loan Origination Fee .


1.1

Purchase and Sale of Note .  The Company hereby sells, transfers, and assigns to the Investor, and the Investor hereby purchases and acquires from the Company, a Note in the principal amount of $500,000 (the "Purchase Price").


1.2

Payment of Purchase Price; Delivery of Note .  Concurrently with the execution and delivery of this Agreement, (a) the Investor is delivering to the Company a certified or cashier's check (or other form of payment acceptable to the Company, in its sole discretion) in an amount equal to the Purchase Price, or shall transfer such sum to the account of the Company by wire transfer, and (b) the Company is delivering, or within a reasonable period of time, will deliver, to the Investor the Note purchased hereunder, which shall be in definitive form registered in the name of the Investor.





2.

Representations, Warranties, and Covenants of Investor .  Investor hereby represents and warrants to, and covenants with, the Company as follows:


2.1

Offshore Transaction .  () Investor is not a U.S. person ("U.S. Person") as that term is defined in Regulation S; () the Note was not offered to Investor in the United States; () at the time of execution of this Agreement and the time of any offer to Investor to purchase the Note hereunder, Investor was physically outside the United States; () Investor is purchasing the Note for Investor’s own account and not for the account of or for the benefit of any U.S. Person; and () Investor is not an underwriter, dealer, distributor, or other person who is participating, pursuant to a contractual arrangement, in the distribution of the Note offered or sold in reliance on Regulation S.


2.2

Investor's Independent Investigation .  Investor, in subscribing for the Note hereunder, has relied solely upon an independent investigation made by Investor and Investor’s representatives, if any, and has, prior to the date hereof, been given access to and the opportunity to examine all books and records of the Company, and all material contracts and documents of the Company which have been filed as exhibits to the Company's filings made under the Act and the Securities Exchange Act of 1934, as amended (the "Exchange Act").  In making Investor’s investment decision to purchase the Note, Investor is not relying on any oral or written representations or assurances from the Company or any other person other than as set forth in this Agreement.  Investor has received and reviewed the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006 and the Company's Form 10-QSB for the quarters ended March 31, 2007 and June 30, 2007.  Investor has such experience in business and financial matters that Investor is capable of evaluating the risk of Investor’s investment and determining the suitability of Investor’s investment.  Investor is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Act.  


2.3

Investor's Economic Risk .  Investor understands and acknowledges that an investment in the Note involves a high degree of risk.  Investor acknowledges that there are limitations on the liquidity of the Note.  Investor represents that Investor is able to bear the economic risk of an investment in the Note, including a possible total loss of investment.  In making this statement Investor hereby represents and warrants to the Company that Investor has adequate means of providing for Investor's current needs and contingencies; and that Investor is able to afford to hold the Note for an indefinite period.  Further, Investor has no present need for liquidity in the Note and Investor is willing to accept such investment risks.


2.4

No Government Recommendation or Approval .  Investor understands that no United States federal or state agency, or similar agency of any other country, has reviewed, approved, passed upon, or made any recommendation or endorsement of the Company or the purchase of the Note.








2.5

Company's Reliance on Representations of Investor .  Investor understands that the Note is being offered and sold to Investor in reliance on specific exemptions from the registration requirements of U.S. securities laws and that the Company is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments, and understandings of Investor set forth herein in order to determine the applicability of such exemptions to Investor’s acquisition of the Note and suitability to acquire the Note.


2.6

Note Not Registered Under the Act or Any State Act .  Investor understands that the offer and sale of the Note has not been registered under the Act or any state securities laws ("State Acts") and that they are being offered and sold and delivered pursuant to Regulation S based in part upon the representations of Investor contained herein.  The Note may not be offered, sold, or otherwise transferred in the United States or to U.S. Persons unless such offers, sales, and transfers are registered under the Act and applicable State Acts or are made pursuant to an available exemption from the registration requirements of those laws.


2.7

Investment Intent .  Investor is acquiring the Note for Investor’s own account for investment and not as a nominee and not with a view to the distribution thereof.  Investor understands that Investor must bear the economic risk of this investment indefinitely unless the Note is registered pursuant to the Act and any applicable State Acts, or an exemption from such registration is available.  Investor represents and warrants to the Company, as of the date of this Agreement, that Investor has no present plan or intention to sell the Note in the United States at any predetermined time, and has made no predetermined arrangements to sell the Note.


2.8

Investor's Power and Authority .  Investor has the full power and authority to execute, deliver, and perform this Agreement.  This Agreement, when executed and delivered by Investor, will constitute a valid and legally binding obligation of Investor, enforceable in accordance with its terms.


2.9

Representation Regarding Signatory .  Investor represents and warrants that Investor's signatory, if any, is duly authorized to execute this Agreement on behalf of Investor.


2.10

No Tax Advice From Company or Its Agents .  Investor has had an opportunity to review with Investor’s own tax advisors the foreign, U.S. federal, state and local tax consequences of this investment, and the transactions contemplated by this Agreement.  Investor is relying solely on such advisors and not on any statements or representations of the Company or any of its agents and understands that Investor (and not the Company) shall be responsible for Investor's own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement.










2.11

No Legal Advice from Company or Its Agents .  Investor acknowledges that Investor has had the opportunity to review this Agreement and the transac


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more